The mainstay of therapy of large vessel vasculitides (LVV) remains glucocorticoids (GC). Although most patients initially achieve disease remission, relapses and GC dependence are seen in more than two-thirds of cases. Conventional synthetic disease-modifying antirheumatic drugs (DMARDs) showed little or no steroid sparing effects, while biological agents represent a valid therapeutic option in patients with severe and/or relapsing LVV.

Biotherapies in large vessel vasculitis / Pazzola, G; Muratore, Francesco; Pipitone, N; Salvarani, Carlo. - In: REVUE DE MEDECINE INTERNE. - ISSN 0248-8663. - 37:4(2016), pp. 274-278. [10.1016/j.revmed.2015.08.012]

### Biotherapies in large vessel vasculitis

### Pazzola, G;MURATORE, Francesco;Pipitone, N;SALVARANI, CARLO

### 2016

### Abstract

### Scheda breve Scheda completa Scheda completa (DC)

<table class="table card-body">
<tr>
<th class="standard" id="t1">File</th>
<th class="standard d-none d-sm-table-cell" id="t3">Dimensione</th>
<th class="standard d-none d-sm-table-cell" id="t4">Formato</th>
<th class="standard d-none d-sm-table-cell" id="t5"> </th>
</tr>
<tr>
<td class="standard break-all" headers="t1">
									
										
										
										
										
											
												
												
												    
												
											
										
									
									
										
										
											1-s2.0-S0248866315006347-main.pdf
										
																				
									
										
											<p class="badge bg-info">Accesso riservato</p>
<div class="col-12 mb-2">
											Tipologia:
											VOR - Versione pubblicata dall'editore
										</div>
<div class="col-12 mb-2 d-block d-sm-none">
										Dimensione
										596.79 kB
									</div>
<div class="col-12 mb-2 d-block d-sm-none">
										Formato
										Adobe PDF
									</div>
<div class="col-12 mb-2 d-block d-sm-none">
<a class="btn btn-warning" href="/retrieve/e31e124f-60fc-987f-e053-3705fe0a095a/1-s2.0-S0248866315006347-main.pdf" rel="noopener" target="_blank"><span class="fas fa-lock"></span>  Visualizza/Apri</a>
<a class="btn btn-warning" href="/request-item?handle=11380/1079753&amp;bitstreamId=e31e124f-60fc-987f-e053-3705fe0a095a"><span class="fas fa-lock"></span>  Richiedi una copia</a>
</div>
</td>
<td class="standard d-none d-sm-table-cell" headers="t3">596.79 kB</td>
<td class="standard d-none d-sm-table-cell" headers="t4">Adobe PDF</td>
<td class="standard d-none d-sm-table-cell">
<a class="btn btn-warning" href="/retrieve/e31e124f-60fc-987f-e053-3705fe0a095a/1-s2.0-S0248866315006347-main.pdf" rel="noopener" target="_blank"><span class="fas fa-lock"></span>  Visualizza/Apri</a>
<a class="btn btn-warning" href="/request-item?handle=11380/1079753&amp;bitstreamId=e31e124f-60fc-987f-e053-3705fe0a095a"><span class="fas fa-lock"></span>  Richiedi una copia</a>
</td>
</tr>
</table>

### Pubblicazioni consigliate

I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione. In caso di violazione di copyright, contattare Supporto Iris

### Informazioni

### Citazioni

- 2

- 6

- 5

### social impact

### Conferma cancellazione

Sei sicuro che questo prodotto debba essere cancellato?

### simulazione ASN

### Errore

### Errore